Cargando…
Prognostic impact of Schlafen 11 in bladder cancer patients treated with platinum‐based chemotherapy
The utility of Schlafen 11 (SLFN11) expression as a predictive biomarker for platinum‐based chemotherapy has been established for cancers from different histologies. However, the therapeutic relevance of SLFN11 in bladder cancer (BC) is unknown. Here, we examined the clinicopathologic significance o...
Autores principales: | Taniyama, Daiki, Sakamoto, Naoya, Takashima, Tsuyoshi, Takeda, Masahiko, Pham, Quoc Thang, Ukai, Shoichi, Maruyama, Ryota, Harada, Kenji, Babasaki, Takashi, Sekino, Yohei, Hayashi, Tetsutaro, Sentani, Kazuhiro, Pommier, Yves, Murai, Junko, Yasui, Wataru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819307/ https://www.ncbi.nlm.nih.gov/pubmed/34808009 http://dx.doi.org/10.1111/cas.15207 |
Ejemplares similares
-
TDO2 overexpression correlates with poor prognosis, cancer stemness, and resistance to cetuximab in bladder cancer
por: Pham, Quoc Thang, et al.
Publicado: (2021) -
Clinicopathologic features of TDO2 overexpression in renal cell carcinoma
por: Pham, Quoc Thang, et al.
Publicado: (2021) -
Schlafen family member 11 indicates favorable prognosis of patients with head and neck cancer following platinum-based chemoradiotherapy
por: Hamada, Seijiro, et al.
Publicado: (2023) -
Overexpression of claspin promotes docetaxel resistance and is associated with prostate‐specific antigen recurrence in prostate cancer
por: Babasaki, Takashi, et al.
Publicado: (2021) -
KHDRBS3 promotes multi‐drug resistance and anchorage‐independent growth in colorectal cancer
por: Ukai, Shoichi, et al.
Publicado: (2021)